Keywords: tentative, fda, ok, osi/genentech, tarceva, drugmakers, osi

Tentative FDA OK for OSI/Genentech's Tarceva

Article | 19 September 2005

US drugmakers OSI Pharmaceuticals and Genentech says that the oncologic drug advisory committee of the Food and Drug Administration has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in